Risk culture: Ensuring responsible AI innovation in healthcare
Description
The discussion explores the intersection of AI and healthcare at MIT's Jameel Clinic. Ignacio Fuentes highlights their work in clinical AI, particularly in oncology, and drug discovery, including a new protein folding model. Frank Schuler emphasizes the role of accountants in building trust and managing AI risks in healthcare, suggesting future audits of AI systems. They discuss the importance of ethical decision-making, data quality, and regulatory frameworks. The clinic's global network of 43 hospitals aims to validate and implement AI models, enhancing early disease detection and clinical efficiency. The conversation underscores the need for collaboration among accountants, doctors, and policymakers to navigate AI's transformative impact on healthcare.
United States
